Search Results for "Skyla"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Skyla. Results 1 to 6 of 6 total matches.
See also: levonorgestrel

A New Low-Dose Levonorgestrel-Releasing IUD (Skyla)

   
The Medical Letter on Drugs and Therapeutics • Mar 18, 2013  (Issue 1412)
A New Low-Dose Levonorgestrel-Releasing IUD (Skyla) ...
The FDA recently approved Skyla (Bayer), the first new intrauterine device (IUD) in the US in 12 years. It releases levonorgestrel, a synthetic progestin, over a period of 3 years. A table summarizing contraceptive methods available in the US appears on page 22.
Med Lett Drugs Ther. 2013 Mar 18;55(1412):21-2 |  Show IntroductionHide Introduction

Liletta - A Third Levonorgestrel-Releasing IUD

   
The Medical Letter on Drugs and Therapeutics • Jul 06, 2015  (Issue 1472)
— Liletta is the same size as Mirena and slightly larger than Skyla. It has a 32x32mm T-shaped plastic ...
The FDA has approved Liletta, an intrauterine device (IUD) that releases the synthetic progestin levonorgestrel, for prevention of pregnancy for up to 3 years. The fourth IUD to be approved in the US, and the third that releases levonorgestrel, Liletta is comarketed by Actavis and Medicines360, a nonprofit women's health pharmaceutical company. The wholesale cost of Liletta is similar to that of other IUDs (see Table 1), but the manufacturer offers programs that significantly reduce the cost for commercially-insured patients and clinics serving low-income women.
Med Lett Drugs Ther. 2015 Jul 6;57(1472):99-100 |  Show IntroductionHide Introduction

Kyleena - Another Hormonal IUD

   
The Medical Letter on Drugs and Therapeutics • Feb 27, 2017  (Issue 1515)
0.15 52 mg 684.40 (Allergan/Actavis) Mirena (Bayer)5 5 years 0.2 52 mg 858.30 Skyla (Bayer) 3 years ...
The FDA has approved Kyleena (Bayer), an intrauterine device (IUD) that releases the synthetic progestin levonorgestrel, for prevention of pregnancy. It is the fourth levonorgestrel-releasing IUD to be approved in the US. Like Mirena, which has been available since 2000, Kyleena is approved for up to 5 years of use.
Med Lett Drugs Ther. 2017 Feb 27;59(1515):38-9 |  Show IntroductionHide Introduction

Phexxi - A Nonhormonal Contraceptive Gel

   
The Medical Letter on Drugs and Therapeutics • Aug 24, 2020  (Issue 1605)
IUDs Kyleena (Bayer) Liletta (Abbvie/Medicines 360) Mirena (Bayer) Skyla (Bayer) 0.2% 0.1% 0.1 ...
The FDA has approved Phexxi (Evofem), a nonhormonal prescription-only vaginal gel containing lactic acid, citric acid, and potassium bitartrate, for prevention of pregnancy. The gel is intended for on-demand contraception; it is not effective when used after intercourse. It was previously approved for use as a vaginal lubricant (Amphora), but was never marketed.
Med Lett Drugs Ther. 2020 Aug 24;62(1605):129-32 |  Show IntroductionHide Introduction

Miudella – A Lower-Dose Copper IUD

   
The Medical Letter on Drugs and Therapeutics • Apr 28, 2025  (Issue 5106)
, was approved in 1984. Four hormonal IUDs (Mirena, Liletta, Skyla, Kyleena) that release the progestin ...
Miudella (Sebela), a copper intrauterine device (IUD), has been approved by the FDA for prevention of pregnancy for up to 3 years. Miudella is the second copper IUD to be approved in the US; ParaGard, which contains more copper and is approved for up to 10 years of use, was approved in 1984. Four hormonal IUDs (Mirena, Liletta, Skyla, Kyleena) that release the progestin levonorgestrel are also available for pregnancy prevention (see Table 2).
Med Lett Drugs Ther. 2025 Apr 28;67(5106):1-2   doi:10.58347/tml.2025.5106a |  Show IntroductionHide Introduction

Choice of Contraceptives

   
The Medical Letter on Drugs and Therapeutics • May 15, 2023  (Issue 1676)
) Levonorgestrel 13.5 mg (Skyla) 0.1% 0.2% 0.4% 0.1% 0.2% 0.3% Mirena and Liletta approved for up to 8 ...
Intrauterine devices (IUDs) and the etonogestrel implant are the most effective reversible contraceptive methods available. Hormonal oral contraceptives, patches, rings, and injectables are also effective in preventing pregnancy. When used alone, barrier and behavioral methods generally have higher failure rates than other methods (see Table 1). Selection of a contraceptive method is usually based on patient-specific factors and personal preference
Med Lett Drugs Ther. 2023 May 15;65(1676):73-80   doi:10.58347/tml.2023.1676a |  Show IntroductionHide Introduction